{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:08:01Z","timestamp":1787836081923,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Natural Science Basic Research Plan in Shaanxi Province of China","award":["2014JM4155"],"award-info":[{"award-number":["2014JM4155"]}]},{"name":"Shaanxi Province Science Association","award":["20170409"],"award-info":[{"award-number":["20170409"]}]}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.mehy.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T21:09:23Z","timestamp":1521493763000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ratio of CD147 high \/CD147 low in CD4 + CD25 + T cells: A potential biomarker for early diagnosis and prediction of response to therapy for autoimmune diseases"],"prefix":"10.1016","volume":"115","author":[{"given":"Huifang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mehy.2018.03.005_b0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mehy.2018.03.005_b0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2018.03.005_b0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2018.03.005_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coi.2015.09.002","article-title":"Targeting Treg signaling for the treatment of autoimmune diseases","volume":"37","author":"Spence","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.mehy.2018.03.005_b0025","doi-asserted-by":"crossref","first-page":"37559","DOI":"10.1038\/srep37559","article-title":"Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.mehy.2018.03.005_b0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11926-013-0352-0","article-title":"Treg cells in rheumatoid arthritis: an update","volume":"15","author":"Cooles","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.mehy.2018.03.005_b0035","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.38715","article-title":"Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway","volume":"66","author":"Cribbs","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.mehy.2018.03.005_b0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2337\/db09-0694","article-title":"Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects","volume":"59","author":"Long","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mehy.2018.03.005_b0045","first-page":"240","article-title":"Altered suppressor function of regulatory T cells in type 1 diabetes","volume":"12","author":"Aghili","year":"2015","journal-title":"Iran J Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2018.03.005_b0050","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"issue":"7404","key":"10.1016\/j.mehy.2018.03.005_b0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mehy.2018.03.005_b0060","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.mehy.2018.03.005_b0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2018.03.005_b0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12026-017-8904-4","article-title":"Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus","volume":"65","author":"Schmidt","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.mehy.2018.03.005_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.mehy.2018.03.005_b0080","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/cti.2017.18","article-title":"Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis","volume":"6","author":"Jones","year":"2017","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2018.03.005_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflamm"},{"issue":"6","key":"10.1016\/j.mehy.2018.03.005_b0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/MOT.0b013e32834017ae","article-title":"CD4+ regulatory T cells in solid organ transplantation","volume":"15","author":"Issa","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"6","key":"10.1016\/j.mehy.2018.03.005_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015545","article-title":"Regulatory cells and transplantation tolerance","volume":"3","author":"Cobbold","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.mehy.2018.03.005_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrneph.2014.35","article-title":"Immunology: TREG cells in transplantation-a double-edged sword?","volume":"10","author":"Lakkis","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.mehy.2018.03.005_b0105","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.4049\/jimmunol.168.10.4946","article-title":"A role for CD147 in thymic development","volume":"168","author":"Renno","year":"2002","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.mehy.2018.03.005_b0110","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1182\/blood-2011-02-339242","article-title":"CD147 (Basigin\/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells","volume":"118","author":"Solstad","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mehy.2018.03.005_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellimm.2013.04.008","article-title":"CD147 in regulatory T cells","volume":"282","author":"Landskron","year":"2013","journal-title":"Cell Immunol"},{"issue":"22","key":"10.1016\/j.mehy.2018.03.005_b0120","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.mehy.2018.03.005_b0125","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mehy.2018.03.005_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clim.2015.04.005","article-title":"Biomarkers for rheumatoid and psoriatic arthritis","volume":"161","author":"Verheul","year":"2015","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2018.03.005_b0135","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1756-185X.12779","article-title":"The ongoing quest for biomarkers in Ankylosing Spondylitis","volume":"18","author":"Danve","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.mehy.2018.03.005_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.mehy.2018.03.005_b0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"315","key":"10.1016\/j.mehy.2018.03.005_b0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.mehy.2018.03.005_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat Rev Rheumatol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717312823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717312823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:18:27Z","timestamp":1570925907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717312823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":31,"alternative-id":["S0306987717312823"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.03.005","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ratio of CD147high\/CD147low in CD4+CD25+ T cells: A potential biomarker for early diagnosis and prediction of response to therapy for autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}